08.08.2023 04:11:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEWR, RETA, INPX, PACW

NEW YORK, Aug. 7, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

New Relic, Inc. (NYSE: NEWR)'s sale to Francisco Partners for $87.00 per share in cash. If you are a New Relic shareholder, click here to learn more about your rights and options.  

Reata Pharmaceuticals, Inc. (NASDAQ: RETA)'s sale to Biogen Inc. for $172.50 per share in cash. If you are a Reata shareholder, click here to learn more about your rights and options.

Inpixon (NASDAQ: INPX)'s merger with XTI Aircraft Company. Upon closing of the proposed transaction, Inpixon shareholders are expected to own approximately 40% of the combined company. If you are an Inpixon shareholder, click here to learn more about your rights and options.

PacWest Bancorp (NASDAQ: PACW)'s sale to Banc of California, Inc. for 0.6569 of a share of Banc of California common stock for each share of PacWest common stock. If you are a PacWest shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-newr-reta-inpx-pacw-301895143.html

SOURCE Halper Sadeh LLP

Nachrichten zu Reata Pharmaceuticals Inc (A)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Reata Pharmaceuticals Inc (A)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!